ATE369150T1 - Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe - Google Patents

Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe

Info

Publication number
ATE369150T1
ATE369150T1 AT95941347T AT95941347T ATE369150T1 AT E369150 T1 ATE369150 T1 AT E369150T1 AT 95941347 T AT95941347 T AT 95941347T AT 95941347 T AT95941347 T AT 95941347T AT E369150 T1 ATE369150 T1 AT E369150T1
Authority
AT
Austria
Prior art keywords
composition
body surface
compositions
electrotransport
active delivery
Prior art date
Application number
AT95941347T
Other languages
English (en)
Inventor
James A Huntington
Michel Cormier
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE369150T1 publication Critical patent/ATE369150T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Centrifugal Separators (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT95941347T 1994-11-14 1995-11-01 Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe ATE369150T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/338,924 US5736580A (en) 1994-11-14 1994-11-14 Composition, device, and method for electrotransport agent delivery

Publications (1)

Publication Number Publication Date
ATE369150T1 true ATE369150T1 (de) 2007-08-15

Family

ID=23326715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941347T ATE369150T1 (de) 1994-11-14 1995-11-01 Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe

Country Status (10)

Country Link
US (3) US5736580A (de)
EP (1) EP0789589B1 (de)
JP (1) JP4049389B2 (de)
AT (1) ATE369150T1 (de)
CA (1) CA2201725C (de)
DE (1) DE69535556T2 (de)
DK (1) DK0789589T3 (de)
ES (1) ES2292171T3 (de)
PT (1) PT789589E (de)
WO (1) WO1996014869A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US8321013B2 (en) * 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． 電気的筋肉制御装置
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6119036A (en) * 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
CA2308489A1 (en) 1997-10-09 1999-04-22 Emory University Method and devices for transdermal delivery of lithium
EP0922467A3 (de) * 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8019421B2 (en) * 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6477410B1 (en) 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
DE19923427A1 (de) 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
US7092753B2 (en) * 1999-06-04 2006-08-15 Impulse Dynamics Nv Drug delivery device
US7190997B1 (en) 1999-06-04 2007-03-13 Impulse Dynamics Nv Drug delivery device
US7171263B2 (en) * 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US7069226B1 (en) 1999-07-07 2006-06-27 Synetic, Incorporated Prescription data processing system for determining new therapy starts
US7151191B2 (en) * 2000-01-13 2006-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
AU2003282683A1 (en) * 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
CN1856338B (zh) 2003-07-21 2012-11-14 超治疗有限公司 用于治疗疾病和控制血糖的胃肠方法和装置
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
US8548583B2 (en) 2004-03-10 2013-10-01 Impulse Dynamics Nv Protein activity modification
CA2594673A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
US8296162B1 (en) 2005-02-01 2012-10-23 Webmd Llc. Systems, devices, and methods for providing healthcare information
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US8380530B2 (en) 2007-02-02 2013-02-19 Webmd Llc. Personalized health records with associative relationships
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US20090137925A1 (en) * 2007-11-23 2009-05-28 Divya Cantor Impedance Spectroscopy Cervix Scanning Apparatus and Method
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
US20110087153A1 (en) * 2009-10-13 2011-04-14 Angelov Angel S Transdermal Methods And Systems For The Delivery Of Rizatriptan
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
JP6243102B2 (ja) * 2012-05-01 2017-12-06 株式会社ジェムインターナショナル 貼付剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084241A (en) * 1982-09-20 1992-01-28 V-Tech, Inc. Apparatus including a sample petter tube for obtaining reproducible liquid samples of small volume
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
US4722720A (en) * 1985-04-30 1988-02-02 Nhk Spring Co., Ltd. Tension providing device
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
DE3724691C2 (de) * 1987-07-25 1999-03-18 Konrad Minninger Pharmazeutisches Mittel zur lokalen Therapie von schuppenden Hautkrankheiten
DE58904851D1 (de) * 1989-01-25 1993-08-05 Wolff Chem Pharm Gmbh Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
US5087242A (en) * 1989-07-21 1992-02-11 Iomed, Inc. Hydratable bioelectrode
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
US5087241A (en) * 1990-07-24 1992-02-11 Empi, Inc. Iontophoresis electrode with reservoir and injection site
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
FI931915L (fi) * 1990-10-29 1993-04-28 Alza Corp Iontoforetisk laekemedelavgivningselektrod och foerfarande foer dess hydratisering
ES2120477T3 (es) * 1992-01-21 1998-11-01 Macrochem Corp Administracion iontoforetica de medicamentos perfeccionada.
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物

Also Published As

Publication number Publication date
HK1000450A1 (en) 2008-04-03
EP0789589A1 (de) 1997-08-20
CA2201725A1 (en) 1996-05-23
DE69535556T2 (de) 2008-03-06
DK0789589T3 (da) 2007-12-17
US5736580A (en) 1998-04-07
US6057374A (en) 2000-05-02
CA2201725C (en) 2008-06-03
PT789589E (pt) 2007-08-31
DE69535556D1 (de) 2007-09-20
JPH10508849A (ja) 1998-09-02
EP0789589B1 (de) 2007-08-08
ES2292171T3 (es) 2008-03-01
JP4049389B2 (ja) 2008-02-20
US5811465A (en) 1998-09-22
WO1996014869A1 (en) 1996-05-23

Similar Documents

Publication Publication Date Title
DE69535556D1 (de) Zusammensetzungen, vorrichtung und verfahren zur elektrotransport-wirkstoffabgabe
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
EP1582210A3 (de) Mittel und Verfahren zur Behandlung oder Vorbeugung der chirurgischen Adhäsionen
ATE224753T1 (de) Vorrichtung zur verabreichung von medikamenten durch elektrotransport
ATE170769T1 (de) Vorrichtung zur verabreichung von medikamenten durch elektrotransport
DE69623608D1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
ATE261721T1 (de) System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
CY1117668T1 (el) Φαρμακευτικες συστασεις περιλαμβανουσες ινσουλινη συμπλοκοποιημενη με μια δικετοπιπεραζινη
PT737066E (pt) Dispositivo transdermico contendo polivinilpirrolidona como potenciador de solubilidade
EP1336600A3 (de) Dimer-selektive rxr Modulatoren und Verfahren zu ihrer Verwendung
DE69415694D1 (de) Ionisch leitendes Mittel, System für den kathodischen Schutz von galvanisch aktiven Metallen und Verfahren und Vorrichgtung für dessen Anwendung.
MY125556A (en) Aqueous formulations of peptide
EP1262206A3 (de) Kontrastmittelabgabesystem mit patientenspezifischer Dosierung
HUP9802773A2 (en) Transcorneal drug-release system
ATE155045T1 (de) Vorrichtung zur verabreichung von heilmitteln
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
EP0922467A3 (de) Iontophoretische Verabreichung von Medikamenten
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
WO1998057620A3 (en) Inositol for modulation of immune response
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
DE69613370D1 (de) Zusammensetzung und verfahren zur verstärkung von elektrotransport-wirkstoffzufuhr
CA2282682A1 (en) Tazarotene and corticosteroid treatment for psoriasis
DE3271605D1 (en) Improvements in or relating to electrotherapeutic apparatus
ATE262921T1 (de) Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0789589

Country of ref document: EP